US generic/specialty pharmaceutical manufacturer, ceased operations after Chapter 7 bankruptcy in 2023.
Manufacturer: Akorn Pharmaceuticals, United States
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen